Table 5.
Parameters | Control male | Treated male | Control female | Treated female |
---|---|---|---|---|
WBC (103/µl) | 10.24 ± 0.92 | 10.55 ± 0.86 | 11.59 ± 0.73 | 10.11 ± 0.93 |
RBC (106/µl) | 8.66 ± 0.33 | 8.46 ± 0.29 | 8.23 ± 0.22 | 9.12 ± 0.23 |
HGB (g/dl) | 14.62 ± 0.82 | 15.50 ± 0.60 | 15.73 ± 0.62 | 15.17 ± 0.78 |
HCT (%) | 44.7 ± 1.54 | 45.55 ± 1.75 | 46.53 ± 1.57 | 45.03 ± 0.78 |
MCV (fl) | 56.2 ± 0.87 | 53.90 ± 0.62 | 56.7 ± 0.24 | 59.13 ± 1.13 |
MCH (pg) | 18.81 ± 0.25 | 18.35 ± 0.15 | 17.93 ± 0.48 | 18.43 ± 0.29 |
MCHC (g/dl) | 30.8 ± 0.28 | 34.00 ± 0.18 | 31.7 ± 0.42 | 31.20 ± 0.48 |
PLT (103/µl) | 1202 ± 42.46 | 1320 ± 50.37 | 1333.33 ± 48.73 | 1239 ± 67.10 |
NEUT (%) | 9.3 ± 1.22 | 7.6 ± 1.51 | 8.36 ± 1.10 | 9.07 ± 1.96 |
LYMP (%) | 80.5 ± 3.03 | 74.2 ± 5.83 | 78.9 ± 1.15 | 77.70 ± 1.04 |
MONO (%) | 6.27 ± 0.46 | 6.4 ± 0.51 | 7.36 ± 0.68 | 7.20 ± 0.53 |
EO (%) | 1.76 ± 0.1 | 1.7 ± 0.15 | 1.13 ± 0.13 | 1.77 ± 0.12 |
BASO (%) | 0.4 ± 0.01 | 0.40 ± 0.05 | 0.43 ± 0.02 | 0.37 ± 0.05 |
RET (%) | 3.13 ± 0.35 | 3.20 ± 0.25 | 3.52 ± 0.27 | 3.10 ± 0.18 |
The values are expressed as mean ± SEM. n = 5 in each group.
p < 0.05 as compared with controls (one-way ANOVA).